+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Soft Tissue Repair Market (2021-2026) by Product, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5503457
  • Report
  • November 2021
  • Region: Global
  • 182 Pages
  • Infogence Global Research
The Global Soft Tissue Repair Market is estimated to be USD 10.4 Bn in 2021 and is expected to reach USD 16.9 Bn by 2026, growing at a CAGR of 10.2%.

Market Dynamics

Soft tissue injuries involve damage to muscles, tendons, and ligaments that result in pain and inflammation. The soft tissue repair process is characterized by replacing the injured or damaged tissues with healthy tissues. The current treatment options rely heavily on surgical procedures, which have a low success rate. Therefore, it is imperative to find superior, technologically advanced alternatives such as minimally invasive procedures and rapid healing products. Factors such as lack of substitutes, increase in incidences of soft tissue injuries, increasing participation in sports activities, increasing ageing population and obesity rate and geographic expansion by leading players in developing countries are driving the market. Whereas the high cost of surgical procedures, and limited or lack of reimbursement are restraining factors for the market.

Growing investment potential in emerging markets provides an opportunity for the market but lack of awareness and limited reimbursement policies acts as a challenge to it.

Market Segmentation

The Global Soft Tissue Repair Market is segmented further based on Product, Application And Geography.

By Product, the market is classified into Tissue Patch/Mesh, Fixation Products and Laparoscopic Instruments segments. Amongst all segments, the Laparoscopic Instruments segment is expected to grow at the highest CAGR.

By Application, the market is classified into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopaedic, Dental and Breast Reconstruction Repair segments. Amongst all, the Hernia Repair segment is expected to contribute the highest growth.

By Geography, North America is projected to lead the market.

Recent Developments

1. Orthocell’s strong cash balance allows the company to progress key regulatory approvals and commercialisation strategy - 4th May 2021
2. CollPlant announces the development and global commercialization agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products - 8th February 2021

Company Profiles

Some of the companies covered in this report are Smith & Nephew PLC, Becton, Dickinson and Company (C.R. Bard), Allergan Plc. (LifeCell Corporation), Athersys, Inc., Wright Medical, CryoLife, Inc., Johnson & Johnson, etc.

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Soft Tissue Repair Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Soft Tissue Repair Market

What is the estimated value of the Global Soft Tissue Repair Market?

The Global Soft Tissue Repair Market was estimated to be valued at $10400.0 Million in 2021.

What is the growth rate of the Global Soft Tissue Repair Market?

The growth rate of the Global Soft Tissue Repair Market is 10.2%, with an estimated value of $16900.0 Million by 2026.

What is the forecasted size of the Global Soft Tissue Repair Market?

The Global Soft Tissue Repair Market is estimated to be worth $16900.0 Million by 2026.

Who are the key companies in the Global Soft Tissue Repair Market?

Key companies in the Global Soft Tissue Repair Market include Smith & Nephew PLC, Becton, Dickinson and Company (C.R. Bard), Allergan Plc. (LifeCell Corporation), Athersys, Inc., Wright Medical, CryoLife, Inc., Johnson & Johnson, Lifenet Health, Inc. and Medtronic Plc..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Lack of Substitutes
4.1.2 Increase in Incidences of Soft Tissue Injuries
4.1.3 Increasing Participation in Sports Activities
4.1.4 Increasing Aging Population and Obesity Rate
4.1.5 Geographic Expansion by Leading Players in Developing Countries
4.2 Restraints
4.2.1 High Cost of Surgical Procedures
4.2.2 Limited or Lack of Reimbursement
4.3 Opportunities
4.3.1 Growing Investment Potential in Emerging Markets
4.4 Challenges
4.4.1 Lack of awareness and limited reimbursement policies
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Soft Tissue Repair Market, By Product
6.1 Introduction
6.2 Tissue Patch/Mesh
6.2.1 Synthetic Mesh
6.2.2 Biological Mesh Allograft Xenograft
6.3 Fixation Products
6.3.1 Suture Anchors
6.3.2 Interference Screws
6.3.3 Other Fixation Devices
6.4 Laparoscopic Instruments
7 Global Soft Tissue Repair Market, By Application
7.1 Introduction
7.2 Hernia Repair
7.3 Dural Repair
7.4 Vaginal Sling Procedures
7.5 Skin Repair
7.6 Orthopaedic
7.7 Dental
7.8 Breast Reconstruction Repair
8 Global Soft Tissue Repair Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 IGR Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Smith & Nephew PLC
10.2 Becton, Dickinson and Company (C.R. Bard)
10.3 Allergan Plc. (LifeCell Corporation)
10.4 Athersys, Inc.
10.5 Wright Medical
10.6 CryoLife, Inc.
10.7 Johnson & Johnson
10.8 Lifenet Health, Inc.
10.9 Arthrex, Inc.
10.10 Medtronic Plc.
10.11 Organogenesis Inc.
10.12 Covidien PLC
10.13 Stryker Corporation
10.14 Zimmer Biomet Holdings, Inc.
10.15 Integra Lifesciences Corporation
10.16 American Medical Systems Inc.
10.17 Orthocell Ltd
10.18 Acera Surgical Inc
10.19 Baxter International Inc.
10.20 Boston Scientific Corporation
10.21 Cerner Corporation
10.22 CONMED Corporation
10.23 GE Healthcare Inc.
10.24 Institut Straumann AG
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Smith & Nephew PLC
  • Becton, Dickinson and Company (C.R. Bard)
  • Allergan Plc. (LifeCell Corporation)
  • Athersys, Inc.
  • Wright Medical
  • CryoLife, Inc.
  • Johnson & Johnson
  • Lifenet Health, Inc.
  • Arthrex, Inc.
  • Medtronic Plc.
  • Organogenesis Inc.
  • Covidien PLC
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Integra Lifesciences Corporation
  • American Medical Systems Inc.
  • Orthocell Ltd
  • Acera Surgical Inc
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Cerner Corporation
  • CONMED Corporation
  • GE Healthcare Inc.
  • Institut Straumann AG